Comparison

Monomethyl auristatin E European Partner

Item no. TMO-T6897-500mg
Manufacturer TargetMol
CASRN 474645-27-7
Amount 500 mg
Quantity options 100 mg 1 mL x 10 mM (in DMSO) 10 mg 1 g 1 mg 1 mL 25 mg 2 mg 500 mg 50 mg 5 mg
Category
Type Molecules
Specific against other
Citations 1. Francisco JA, et al. Blood. 2003, 102(4), 1458-1465.
Smiles CC[C@H](C)C([C@@H](CC(=O)N1CCC[C@H]1C(OC)[C@@H](C)C(=O)N[C@H](C)[C@@H](O)c1ccccc1)OC)N(C)[C@@H](C(C)C)C(=O)NC(=O)[C@@H](NC)C(C)C
ECLASS 10.1 32169090
ECLASS 11.0 32169090
UNSPSC 12000000
Alias MMAE,Vedotin
Shipping Condition Cool pack
Available
Manufacturer - Targets
Apoptosis|||Microtubule Associated|||ADC Cytotoxin
Shipping Temperature
Cool pack
Storage Conditions
-20
Molecular Weight
717.98
Description
Monomethyl auristatin E (MMAE) (MMAE), an antimitotic agent, inhibits cell division by blocking the polymerization of tubulin and also has inhibition of antibody-drug conjugates (ADCs) activity.
Pathways
Apoptosis|||Cytoskeletal Signaling|||Antibody-drug Conjugate/ADC Related
Bioactivity
Monomethyl auristatin E (MMAE) is a synthetic antineoplastic agent, which is linked to a monoclonal antibody (MAB).
Receptor
microtubule

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Amount: 500 mg
Available: In stock
available

Compare

Add to wishlist

Get an offer

Request delivery time

Ask a technical question

Submit a bulk request

Questions about this Product?
 
Close